Vise Technologies Inc. Buys 2,121 Shares of Cardinal Health, Inc. $CAH

Vise Technologies Inc. raised its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 22.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,641 shares of the company’s stock after buying an additional 2,121 shares during the period. Vise Technologies Inc.’s holdings in Cardinal Health were worth $2,590,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Bank of New York Mellon Corp purchased a new stake in shares of Cardinal Health during the second quarter worth $308,640,000. First Nebraska Trust Co acquired a new stake in Cardinal Health during the second quarter valued at $20,050,000. Castlekeep Investment Advisors LLC purchased a new position in Cardinal Health in the second quarter valued at about $1,177,000. Saudi Central Bank grew its stake in Cardinal Health by 87.8% in the second quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock valued at $3,913,000 after purchasing an additional 7,702 shares in the last quarter. Finally, Stack Financial Management Inc acquired a new position in Cardinal Health in the 2nd quarter worth about $24,681,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Up 3.5%

Shares of NYSE:CAH opened at $261.77 on Thursday. The stock has a market capitalization of $60.62 billion, a PE ratio of 36.21, a P/E/G ratio of 1.52 and a beta of 0.53. Cardinal Health, Inc. has a 1 year low of $180.45 and a 1 year high of $262.29. The firm has a fifty day moving average price of $239.14 and a 200 day moving average price of $222.96.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same period last year, the company earned $2.08 earnings per share. The business’s revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were paid a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 28.49%.

Insiders Place Their Bets

In related news, insider Jessica Mayer sold 29,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the sale, the insider directly owned 33,076 shares in the company, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen Mason sold 35,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total value of $8,274,000.00. Following the sale, the chief executive officer directly owned 18,061 shares of the company’s stock, valued at $4,269,620.40. The trade was a 65.96% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last three months. 0.12% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CAH shares. Mizuho raised their price target on Cardinal Health from $250.00 to $280.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 20th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 25th. UBS Group boosted their price target on Cardinal Health from $280.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, October 16th. Evercore restated an “outperform” rating and issued a $270.00 price objective on shares of Cardinal Health in a report on Wednesday, August 12th. Finally, Citigroup raised their price objective on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $270.69.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.